Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 PandemicECHONCT04395833
National Survey on the Lockdown of Children With Disabilities
An observational study of Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic, run by University Hospital, Brest at 1 site in France.
Trial summary
During the COVID-19 pandemic, lockdown measures were established in France affecting the life course of children with disabilities. This study aimed at identifying the experiences, main difficulties and needs of these children and their parents during the lockdown period. Read more about this study
- Who is it for?
- Ages Up to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic
- How many people
- 2,500 participants
- Where
- 1 siteFrance
- Study dates
- 7 Apr 2020to 11 May 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: Children with motor disabilities, with and without associated impairement
Who may be able to join
- -children (age 0-18 years) with motor disabilities (with and without associated impairement), living in France.
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic: Messages From Families Answering the ECHO French National Survey
During the COVID-19 pandemic, lockdown measures were established in France affecting the life course of children with disabilities. This study aimed at identifying the experiences, main difficulties and needs of these children and their parents during the lockdown period.
What is being measured
The primary outcome is the main question the study is designed to answer.
Experience during lockdown
Identify the lived experience, the needs, and difficulties of children with motor disabilities and their parents during the COVID-2019 lockdown
Measured: From the 6th of April 2020 until the 11th of May 2020
Health risk during lockdown
Identify the risks on health of children with motor disabilities due to the COVID-2019 lockdown
Measured: From the 6th of April 2020 until the 11th of May 2020
Impact on medical and rehabilitation follow up
Identify the impact on the medical and rehabilitation follow up of children with disabilities during COVID-19 lockdown
Measured: From the 6th of April 2020 until the 11th of May 2020
Impact on daily living
Identify the impact on the daily living of children with motor disabilities and their families during the COVID-19 lockdown
Measured: From the 6th of April 2020 until the 11th of May 2020
Secondary outcomes (1)
Experience during lockdown
Identify the lived experience, the needs, and difficulties of children without motor disabilities and their parents during the COVID-2019 lockdown
Measured: From the 24th of April 2020 until the 11th of May 2020
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2020
- Study start7 Apr 2020
- Primary completion11 May 2020
- Study completion11 May 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 PandemicStudies of the same condition, open and under way.
- More trials run by University Hospital, BrestThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Family based
- Time perspective
- Cross-sectional
- Enrolment
- 2,500 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Brest
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04395833
- Sponsor's protocol ID
- CHRU de BREST ECHO
- Acronym
- ECHO
- Status last verified
- May 2020
- First submitted
- 15 May 2020
- Last updated
- 20 May 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic: Messages From Families Answering the ECHO French National Survey
- ClinicalTrials.gov ID
- NCT04395833
- Acronym / sponsor ID
- ECHO / CHRU de BREST ECHO
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,500 participants (actual)
- Lead sponsor
- University Hospital, BrestUniversity, hospital or other
- Study start
- 7 Apr 2020 (actual)
- Primary completion
- 11 May 2020 (actual)
- Study completion
- 11 May 2020 (actual)
- First posted
- 20 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
During the COVID-19 pandemic, lockdown measures were established in France affecting the life course of children with disabilities. This study aimed at identifying the experiences, main difficulties and needs of these children and their parents during the lockdown period.
Study design
- Observational model
- Family based
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Children with motor disabilities, with and without associated impairement
Key inclusion criteria (1 listed)
- -children (age 0-18 years) with motor disabilities (with and without associated impairement), living in France.
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Experience during lockdown
Time frame: From the 6th of April 2020 until the 11th of May 2020
Identify the lived experience, the needs, and difficulties of children with motor disabilities and their parents during the COVID-2019 lockdown
Health risk during lockdown
Time frame: From the 6th of April 2020 until the 11th of May 2020
Identify the risks on health of children with motor disabilities due to the COVID-2019 lockdown
Impact on medical and rehabilitation follow up
Time frame: From the 6th of April 2020 until the 11th of May 2020
Identify the impact on the medical and rehabilitation follow up of children with disabilities during COVID-19 lockdown
Impact on daily living
Time frame: From the 6th of April 2020 until the 11th of May 2020
Identify the impact on the daily living of children with motor disabilities and their families during the COVID-19 lockdown
1 secondary outcome
Experience during lockdown
Time frame: From the 24th of April 2020 until the 11th of May 2020
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2020.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic, run by University Hospital, Brest at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Experience during lockdown (time frame: From the 6th of April 2020 until the 11th of May 2020). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2020.